Sorrento Therapeutics Inc
OTC:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
OTC:SRNE
Watchlist
Price: 0.0021 USD -16% Market Closed
Market Cap: 1.2m USD

Wall Street
Price Targets

SRNE Price Targets Summary
Sorrento Therapeutics Inc

There are no price targets for SRNE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sorrento Therapeutics Inc Competitors:
Price Targets
CSL
CSL Ltd
34% Upside
TSHA
Taysha Gene Therapies Inc
183% Upside
NVAX
Novavax Inc
170% Upside
ABBV
Abbvie Inc
17% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
53% Upside
IONS
Ionis Pharmaceuticals Inc
59% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
46% Upside
LYEL
Lyell Immunopharma Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Sorrento Therapeutics Inc

For the last 8 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 42%. The projected CAGR for the next 3 years is 88%.

42%
Past Growth
88%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SRNE's stock price target?
Not Available

SRNE doesn't have any price targets made by Wall Street professionals.

What is Sorrento Therapeutics Inc's Revenue forecast?
Projected CAGR
88%

For the last 8 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 42%. The projected CAGR for the next 3 years is 88%.

Back to Top